Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
Open accessThe DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Abstract
Unhealthy behaviours, including diet and physical activity, coupled with genetic predisposition, drive type 2 diabetes (T2D) occurrence and severity; the present review aims to summarise the most recent nutritional approaches in T2D, outlining unmet needs. Guidelines consistently suggest reducing energy intake to counteract the obesity epidemic, frequently resulting in sarcopenic obesity, a condition associated with poorer metabolic control and cardiovascular disease. Various dietary approaches have been proposed with largely similar results, with a preference for the Mediterranean diet and the best practice being the diet that patients feel confident of maintaining in the long term based on individual preferences. Patient adherence is indeed the pivotal factor for weight loss and long-term maintenance, requiring intensive lifestyle intervention. The consumption of nutritional supplements continues to increase even if international societies do not support their systematic use. Inositols and vitamin D supplementation, as well as micronutrients (zinc, chromium, magnesium) and pre/probiotics, result in modest improvement in insulin sensitivity, but their use is not systematically suggested. To reach the desired goals, patients should be actively involved in the collaborative development of a personalised meal plan associated with habitual physical activity, aiming at normal body weight and metabolic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence from animal models shows that zinc supplementation reduces weight gain, abdominal fat accumulation, hyperinsulinemia, and leptin levels, while improving insulin resistance in obese mice fed a high-fat, high-fructose diet [183].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [183]
In the citing paper
“Evidence from animal models shows that zinc supplementation reduces weight gain, abdominal fat accumulation, hyperinsulinemia, and leptin levels, while improving insulin resistance in obese mice fed a high-fat, high-fructose diet [183].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Intensive lifestyle intervention (ILI) that supports behaviour changes, as initially experienced in the Finnish Diabetes Prevention Study and the U.S. Diabetes Prevention Program [51,52], represents the recommended approach to prevent and/or delay the onset of T2D in prediabetic patients [5].”
BackgroundSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235 · cited 1×
“Their accumulation due to higher synthesis and decreased export in the presence of high insulin concentrations in the portal vein is the likely cause of fatty liver disease, occurring in up to 73% of patients with T2D [33].”
BackgroundLean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 1×
“At 12 months, almost half of participants achieved T2D remission off all glucose-lowering medications [57]; this percentage dropped to 36% at 24 months [58].”
BackgroundCruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668 · cited 1×
“Similar re-sults were provided by the large trial of combination treatment with niacin plus laropiprant [111], where niacin treatment (2 g/day for a median of 3.9 years) was associated with an increased incidence of de novo T2D (rate ratio, 1.32; 95% CI 1.16–1.51) and deterioration in metabolic…”
ResultInfluentialHypovitaminosis D is associated with insulin resistance and β cell dysfunction
Chiu, K. C., Chu, A., Go, V. L. W., & Saad, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.820 · Cited by 1,642
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496 · cited 3×
“The foundation of medical nutrition therapy (MNT) of T2D is to achieve glucose, lipids, and blood pressure within the target range to prevent, delay or manage microvascular and macrovascular complications [36,37].”
BackgroundFragala, M. S., Cadore, E. L., Dorgo, S., Izquierdo, M., Kraemer, W. J., Peterson, M. D., & Ryan, E. D. (2019) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003230 · Cited by 1,290
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102 · cited 2×
“Dietary restrictions are prescribed to reduce the incidence of T2D as well as to improve metabolic control [2], but weight loss is burdened by the loss of muscle mass [3] and sarcopenia adds to age-dependent muscle wasting [4], increasing frailty [5].”
BackgroundMetabolic syndrome: pathophysiology, management, and modulation by natural compounds
Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944717711379 · Cited by 1,097
Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017 · cited 1×
“At 12 months, almost half of participants achieved T2D remission off all glucose-lowering medications [57]; this percentage dropped to 36% at 24 months [58].”
BackgroundScragg, R., Sowers, M., & Bell, C. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2813 · Cited by 963
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
Shang, A., Cao, S.-Y., Xu, X.-Y., Gan, R.-Y., Tang, G.-Y., Corke, H., Mavumengwana, V., & Li, H.-B. (2019) · Foods · doi:10.3390/foods8070246 · Cited by 896 · cited 1×
“Cur-cumin [114], cinnamon [115,116], berberine [117,118], citrus flavonoids [119,120], quercetin [121,122], the bioactive compounds of garlic [123,124], red yeast rice [125] and neem extracts [126] have all demonstrated some activity on insulin sensitivity, but studies are usually of poor quality…”
BackgroundDiabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
The Look AHEAD Research Group (2006) · Obesity · doi:10.1038/oby.2006.84 · Cited by 873
Flegal, K. M., Shepherd, J. A., Looker, A. C., Graubard, B. I., Borrud, L. G., Ogden, C. L., Harris, T. B., Everhart, J. E., & Schenker, N. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26847 · Cited by 819
Felig, P. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.004441 · Cited by 789 · cited 1×
“The link between muscle tissue and the liver is exerted by amino acids (Figure 1) [34].”
BackgroundThe role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
The Gut Microbiota and Inflammation: An Overview
Al Bander, Z., Nitert, M. D., Mousa, A., & Naderpoor, N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207618 · Cited by 756
Lee, J. H., O'Keefe, J. H., Bell, D., Hensrud, D. D., & Holick, M. F. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.050 · Cited by 724
Swerdlow, D. I., Preiss, D., Kuchenbaecker, K. B., Holmes, M. V., Engmann, J. E. L., Shah, T., Sofat, R., Stender, S., Johnson, P. C. D., Scott, R. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61183-1 · Cited by 680
Beaudart, C., Buckinx, F., Rabenda, V., Gillain, S., Cavalier, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1742 · Cited by 676 · cited 1×
“Vitamin D deficiency is associated with reduced muscle mass and strength in the elderly [181], and vitamin D supplementation increased muscle strength, particularly in vitamin D-deficient cases and in the elderly [181].”
BackgroundConcentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Ajani, U. A., McGuire, L. C., & Liu, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1228 · Cited by 666
Pittas, A. G., Harris, S. S., Stark, P. C., & Dawson-Hughes, B. (2007) · Diabetes Care · doi:10.2337/dc06-1994 · Cited by 643
Newly Identified Actions of the Vitamin D Endocrine System*
WALTERS, M. R. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-4-719 · Cited by 593
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 574
Vitamin D and type 2 diabetes: a systematic review
Mitri, J., Muraru, M. D., & Pittas, A. G. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.118 · Cited by 570
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Caraceni, P., Riggio, O., Angeli, P., Alessandria, C., Neri, S., Foschi, F. G., Levantesi, F., Airoldi, A., Boccia, S., Svegliati-Baroni, G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30840-7 · Cited by 536
Self-citationAdiposity, Cardiometabolic Risk, and Vitamin D Status: The Framingham Heart Study
Cheng, S., Massaro, J. M., Fox, C. S., Larson, M. G., Keyes, M. J., McCabe, E. L., Robins, S. J., O'Donnell, C. J., Hoffmann, U., Jacques, P. F., et al. (2010) · Diabetes · doi:10.2337/db09-1011 · Cited by 521
Taylor, R. (2013) · Diabetes Care · doi:10.2337/dc12-1805 · Cited by 485 · cited 1×
“In both obese and nonobese subjects, higher plasma insulin levels have been associated with a linear increase in the rates of hepatic de novo lipogenesis [30], as supported by the hypoglycaemic effects of glucagon suppression of glucagon-receptor antagonists [31,32].”
BackgroundKazi, T. G., Afridi, H. I., Kazi, N., Jamali, M. K., Arain, M. B., Jalbani, N., & Kandhro, G. A. (2008) · Biological Trace Element Research · doi:10.1007/s12011-007-8062-y · Cited by 480
Leenders, M., Verdijk, L. B., van der Hoeven, L., Adam, J. J., van Kranenburg, J., Nilwik, R., & van Loon, L. J. C. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.02.006 · Cited by 480
Dietary and nutritional approaches for prevention and management of type 2 diabetes
Forouhi, N. G., Misra, A., Mohan, V., Taylor, R., & Yancy, W. (2018) · BMJ · doi:10.1136/bmj.k2234 · Cited by 472
Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
Zinc and diabetes — clinical links and molecular mechanisms
Jansen, J., Karges, W., & Rink, L. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.009 · Cited by 439
Rodríguez-Morán, M., & Guerrero-Romero, F. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1147 · Cited by 429 · cited 1×
“Oral magnesium supplementation in subjects with T2D and low magnesium levels have been reported to improve insulin sensitivity and metabolic control [164–166].”
BackgroundRedefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?
Astrup, A., & Finer, N. (2000) · Obesity Reviews · doi:10.1046/j.1467-789x.2000.00013.x · Cited by 428
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
Izzo, A., Massimino, E., Riccardi, G., & Della Pepa, G. (2021) · Nutrients · doi:10.3390/nu13010183 · Cited by 418
ESPEN practical guideline: clinical nutrition in liver disease
Bischoff, S. C., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Plauth, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.09.001 · Cited by 383 · cited 1×
“Unfortunately, there are no specific guidelines for the nutritional treatment of T2D associated with cirrhosis, and individualized, structured nutritional programs are suggested to accomplish the need for restriction of sodium and fluids [190].”
BackgroundFranz, M. J., MacLeod, J., Evert, A., Brown, C., Gradwell, E., Handu, D., Reppert, A., & Robinson, M. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.03.022 · Cited by 349 · cited 1×
“Several dietary patterns have been studied and proposed, but no single dietary pattern should be preferred [8].”
BackgroundSmartphone Applications for Patients' Health and Fitness
Higgins, J. P. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.05.038 · Cited by 347
Effects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysis
Jayawardena, R., Ranasinghe, P., Galappatthy, P., Malkanthi, R., Constantine, G., & Katulanda, P. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-13 · Cited by 346
Plank, L. D., Gane, E. J., Peng, S., Muthu, C., Mathur, S., Gillanders, L., McIlroy, K., Donaghy, A. J., & McCall, J. L. (2008) · Hepatology · doi:10.1002/hep.22367 · Cited by 325
Chen, S., Zhao, X., Ran, L., Wan, J., Wang, X., Qin, Y., Shu, F., Gao, Y., Yuan, L., Zhang, Q., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.015 · Cited by 319 · cited 1×
“Clinical studies in patients with insulin resistance and NAFLD have shown promising results [130], but even moderate alcohol intake is questioned in these patients due to the negative effects of alcohol on hepatic and extrahepatic cancers, which outweigh the possible beneficial effects on the…”
BackgroundAnderson, R. A., Roussel, A.-M., Zouari, N., Mahjoub, S., Matheau, J.-M., & Kerkeni, A. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719034 · Cited by 313
Dietary Magnesium Intake in Relation to Plasma Insulin Levels and Risk of Type 2 Diabetes in Women
Song, Y., Manson, J. E., Buring, J. E., & Liu, S. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.59 · Cited by 304
Hypertension, Diabetes Mellitus, and Insulin Resistance The Role of Intracellular Magnesium
Paolisso, G. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00342-1 · Cited by 300
Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes
Chen, S., Jiang, H., Wu, X., & Fang, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/9340637 · Cited by 300
The Antidiabetic Potential of Quercetin: Underlying Mechanisms
Haddad, P., & Eid, H. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867323666160909153707 · Cited by 299
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s005 · Cited by 299 · cited 4×
“Dietary restrictions are prescribed to reduce the incidence of T2D as well as to improve metabolic control [2], but weight loss is burdened by the loss of muscle mass [3] and sarcopenia adds to age-dependent muscle wasting [4], increasing frailty [5].”
BackgroundInfluentialIkramuddin, S., Korner, J., Lee, W.-J., Thomas, A. J., Connett, J. E., Bantle, J. P., Leslie, D. B., Wang, Q., Inabnet, W. B., Jeffery, R. W., et al. (2018) · JAMA · doi:10.1001/jama.2017.20813 · Cited by 291 · cited 1×
“Although more effective than behaviour change in inducing and sustaining remission of T2D, bariatric surgery also suffers from reduced durability over time [56].”
BackgroundAngeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.009 · Cited by 282
Gandhi, G. R., Vasconcelos, A. B. S., Wu, D.-T., Li, H.-B., Antony, P. J., Li, H., Geng, F., Gurgel, R. Q., Narain, N., & Gan, R.-Y. (2020) · Nutrients · doi:10.3390/nu12102907 · Cited by 279
D‐Chiro‐Inositol – Its Functional Role in Insulin Action and its Deficit in Insulin Resistance
Larner, J. (2002) · Journal of Diabetes Research · doi:10.1080/15604280212528 · Cited by 277
Aoun, A., Darwish, F., & Hamod, N. (2020) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2020.25.2.113 · Cited by 276
Meta-analysis: vitamin D and non-alcoholic fatty liver disease
Eliades, M., Spyrou, E., Agrawal, N., Lazo, M., Brancati, F. L., Potter, J. J., Koteish, A. A., Clark, J. M., Guallar, E., & Hernaez, R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12377 · Cited by 273
Precision nutrition for prevention and management of type 2 diabetes
Wang, D. D., & Hu, F. B. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30037-8 · Cited by 267
Li, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y. (2018) · Nutrients · doi:10.3390/nu10030375 · Cited by 266 · cited 1×
“…significant improvement in HOMA-IR (standardized mean difference = −0.57; 95% CI: −1.09 to −0.04), particularly when vitamin D was administered in large doses and for a short period of time to nonobese, vitamin D deficient patients, or to individuals with optimal glucose control at baseline [106].”
BackgroundInfluentialKostov, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061351 · Cited by 263
Fang, X., Wang, K., Han, D., He, X., Wei, J., Zhao, L., Imam, M. U., Ping, Z., Li, Y., Xu, Y., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0742-z · Cited by 255
Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity
Fukunaka, A., & Fujitani, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020476 · Cited by 252
Huang, H.-Y., Caballero, B., Chang, S., Alberg, A. J., Semba, R. D., Schneyer, C. R., Wilson, R. F., Cheng, T.-Y., Vassy, J., Prokopowicz, G., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-5-200609050-00135 · Cited by 243
Plant-Dominant Low-Protein Diet for Conservative Management of Chronic Kidney Disease
Kalantar-Zadeh, K., Joshi, S., Schlueter, R., Cooke, J., Brown-Tortorici, A., Donnelly, M., Schulman, S., Lau, W.-L., Rhee, C., Streja, E., et al. (2020) · Nutrients · doi:10.3390/nu12071931 · Cited by 243
Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis
Marchesini, G., Fabbri, A., Bianchi, G., Brizi, M., & Zoli, M. (1996) · Hepatology · doi:10.1002/hep.510230523 · Cited by 237
Self-citationHuang, D.-D., Shi, G., Jiang, Y., Yao, C., & Zhu, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109767 · Cited by 229
Qian, F., Korat, A. A., Malik, V., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc16-0513 · Cited by 222 · cited 1×
“SFAs should be replaced with polyunsaturated fatty acids (PUFAs), mainly mixed sources of omega-3/omega-6, and with monounsaturated fatty acids (MUFAs) of vegetable origin whole grains, nuts and seed (rich in alpha-linolenic fatty acid) [36,45].”
BackgroundMeng, Y., Bai, H., Wang, S., Li, Z., Wang, Q., & Chen, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.006 · Cited by 221 · cited 1×
“normal-or high-carb diets on HbA1c and on short-term weight loss, not on long-term weight loss [40].”
BackgroundDiabetes mellitus in patients with cirrhosis: clinical implications and management
Elkrief, L., Rautou, P., Sarin, S., Valla, D., Paradis, V., & Moreau, R. (2016) · Liver International · doi:10.1111/liv.13115 · Cited by 220
Anagnostis, P., Gkekas, N. K., Achilla, C., Papanastasiou, G., Taouxidou, P., Mitsiou, M., Kenanidis, E., Potoupnis, M., Tsiridis, E., & Goulis, D. G. (2020) · Calcified Tissue International · doi:10.1007/s00223-020-00742-y · Cited by 220
Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases
Overbeck, S., Rink, L., & Haase, H. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0003-8 · Cited by 211
Tanase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tarniceriu, C. C., Maranduca, M. A., Lacatusu, C. M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 207
Sievenpiper, J. L., Chan, C. B., Dworatzek, P. D., Freeze, C., & Williams, S. L. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.009 · Cited by 200
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s003 · Cited by 200
Stein, N., & Brooks, K. (2017) · JMIR Diabetes · doi:10.2196/diabetes.8590 · Cited by 191
Resveratrol and diabetes: A critical review of clinical studies
Öztürk, E., Arslan, A. K. K., Yerer, M. B., & Bishayee, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.070 · Cited by 184
Mooren, F. C., Krüger, K., Völker, K., Golf, S. W., Wadepuhl, M., & Kraus, A. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01332.x · Cited by 183
Ojo, O., Ojo, O., Adebowale, F., & Wang, X.-H. (2018) · Nutrients · doi:10.3390/nu10030373 · Cited by 183
Antioxidant Effects of Zinc Supplementation in Tunisians with Type 2 Diabetes Mellitus
Roussel, A.-M., Kerkeni, A., Zouari, N., Mahjoub, S., Matheau, J.-M., & Anderson, R. A. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719310 · Cited by 179
Bock, P. M., Telo, G. H., Ramalho, R., Sbaraini, M., Leivas, G., Martins, A. F., & Schaan, B. D. (2021) · Diabetologia · doi:10.1007/s00125-020-05295-1 · Cited by 176
Newly identified actions of the vitamin D endocrine system
Walters, M. R. (1992) · Endocrine Reviews · doi:10.1210/er.13.4.719 · Cited by 175
Zinc, Copper, Iron, and Chromium Concentrations in Young Patients with Type 2 Diabetes Mellitus
Basaki, M., Saeb, M., Nazıfı, S., & Shamsaei, H. A. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9360-6 · Cited by 173
Mediterranean Diet and Diabetes: Prevention and Treatment
Georgoulis, M., Kontogianni, M., & Yiannakouris, N. (2014) · Nutrients · doi:10.3390/nu6041406 · Cited by 171
Invited Review: Aging and energy balance
Wilson, M.-M. G., & Morley, J. E. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00313.2003 · Cited by 168
Saleem, S., Muhammad, G., Hussain, M. A., & Bukhari, S. N. A. (2018) · Phytotherapy Research · doi:10.1002/ptr.6076 · Cited by 166
Vitamin D, glucose, insulin, and insulin sensitivity
Tai, K., Need, A. G., Horowitz, M., & Chapman, I. M. (2008) · Nutrition · doi:10.1016/j.nut.2007.11.006 · Cited by 165
Xue, L., Yin, R., Howell, K., & Zhang, P. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12711 · Cited by 165
The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes
Hædersdal, S., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.12.003 · Cited by 162
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s008 · Cited by 158 · cited 2×
“Overall, reducing carbohydrate intake for individuals with T2D has been shown to improve blood glucose [6]; a systematic review and meta-analysis (9 studies with 734 patients) confirmed a beneficial effect of low-carb diets vs. normal-or high-carb diets on HbA1c and on short-term weight loss, not…”
BackgroundGarcía-Molina, L., Lewis-Mikhael, A.-M., Riquelme-Gallego, B., Cano-Ibáñez, N., Oliveras-López, M.-J., & Bueno-Cavanillas, A. (2020) · European Journal of Nutrition · doi:10.1007/s00394-019-02147-6 · Cited by 155
Suksomboon, N., Poolsup, N., & Yuwanakorn, A. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12147 · Cited by 154 · cited 2×
“Based on 25 RCTs of chromium supplementation, Suksomboon et al. concluded for positive effects of chromium supplementation on glucose control in patients with diabetes, with no increased risks of adverse events compared with placebo [156].”
BackgroundEffects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
Unfer, V., Nestler, J. E., Kamenov, Z. A., Prapas, N., & Facchinetti, F. (2016) · International Journal of Endocrinology · doi:10.1155/2016/1849162 · Cited by 151
Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus
Grajower, M. M., & Horne, B. D. (2019) · Nutrients · doi:10.3390/nu11040873 · Cited by 148
DASH Eating Plan: An Eating Pattern for Diabetes Management
Campbell, A. P. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0084 · Cited by 145
Chin, S. O., Keum, C., Woo, J., Park, J., Choi, H. J., Woo, J.-T., & Rhee, S. Y. (2016) · Scientific Reports · doi:10.1038/srep34563 · Cited by 140
Zhu, B., Qi, F., Wu, J., Yin, G., Hua, J.-W., Zhang, Q., & Qin, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01449 · Cited by 136
Avenell, A., Cook, J. A., MacLennan, G. S., & McPherson, G. C. (2009) · Age and Ageing · doi:10.1093/ageing/afp109 · Cited by 135
Farvid, M. S., Jalali, M., Siassi, F., & Hosseini, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2458 · Cited by 134
The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial
Leslie, W. S., Ford, I., Sattar, N., Hollingsworth, K. G., Adamson, A., Sniehotta, F. F., McCombie, L., Brosnahan, N., Ross, H., Mathers, J. C., et al. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0406-2 · Cited by 132 · cited 1×
“National and international guidelines for nutritional and lifestyle recommendations are available [5–9], together with protocols to guide weight loss to produce long-term T2D remission [10].”
BackgroundRole of Magnesium in Type 2 Diabetes Mellitus
Feng, J., Wang, H., Jing, Z., Wang, Y., Cheng, Y., Wang, W., & Sun, W. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01922-0 · Cited by 128
Jin, T., Song, Z., Weng, J., & Fantus, I. G. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00285.2017 · Cited by 127
Taylor, B., Woodfall, G., Sheedy, K., O’Riley, M., Rainbow, K., Bramwell, E., & Kellow, N. (2017) · Nutrients · doi:10.3390/nu9050461 · Cited by 126
Niroomand, M., Fotouhi, A., Irannejad, N., & Hosseinpanah, F. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.12.008 · Cited by 124
Mazzotti, A., Caletti, M. T., Brodosi, L., Domizio, S. D., Forchielli, M. L., Petta, S., Bugianesi, E., Bianchi, G. P., & Marchesini, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.013 · Cited by 123
Self-citationVerma, H., & Garg, R. (2017) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12454 · Cited by 121
Wewer Albrechtsen, N. J., Færch, K., Jensen, T. M., Witte, D. R., Pedersen, J., Mahendran, Y., Jonsson, A. E., Galsgaard, K. D., Winther-Sørensen, M., Torekov, S. S., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4535-5 · Cited by 119 · cited 1×
“In both obese and nonobese subjects, higher plasma insulin levels have been associated with a linear increase in the rates of hepatic de novo lipogenesis [30], as supported by the hypoglycaemic effects of glucagon suppression of glucagon-receptor antagonists [31,32].”
BackgroundGalsgaard, K. D., Winther‐Sørensen, M., Ørskov, C., Kissow, H., Poulsen, S. S., Vilstrup, H., Prehn, C. P., Adamski, J., Jepsen, S. L., Hartmann, B., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00198.2017 · Cited by 118
Wang, L., Yang, H., Huang, H., Zhang, C., Zuo, H.-X., Xu, P., Niu, Y.-M., & Wu, S.-S. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02159-0 · Cited by 118
Micronutrient Status in Type 2 Diabetes
Kaur, B., & Henry, C. J. (2014) · Advances in food and nutrition research · doi:10.1016/b978-0-12-800270-4.00002-x · Cited by 115
Effects of polyunsaturated fatty acid consumption in diabetic nephropathy
Shapiro, H., Theilla, M., Attal-Singer, J., & Singer, P. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.156 · Cited by 115
Accuracy of Specific BIVA for the Assessment of Body Composition in the United States Population
Buffa, R., Saragat, B., Cabras, S., Rinaldi, A. C., & Marini, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058533 · Cited by 115
Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion
Pérez-Rubio, K. G., González-Ortiz, M., Martínez-Abundis, E., Robles-Cervantes, J. A., & Espinel-Bermúdez, M. C. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0183 · Cited by 113 · cited 1×
“Cur-cumin [114], cinnamon [115,116], berberine [117,118], citrus flavonoids [119,120], quercetin [121,122], the bioactive compounds of garlic [123,124], red yeast rice [125] and neem extracts [126] have all demonstrated some activity on insulin sensitivity, but studies are usually of poor quality…”
BackgroundMarini, E., Buffa, Saragat, Coin, Berton, Manzato, Sergi, & Toffanello, E. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s38488 · Cited by 112
Dietary Intake and Type 2 Diabetes
Ojo, O. (2019) · Nutrients · doi:10.3390/nu11092177 · Cited by 110
The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients
ELDerawi, W. A., Naser, I. A., Taleb, M., & Abutair, A. S. (2018) · Nutrients · doi:10.3390/nu11010044 · Cited by 109
Parham, M., Amini, M., Aminorroaya, A., & Heidarian, E. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.102 · Cited by 108
Deyno, S., Eneyew, K., Seyfe, S., Tuyiringire, N., Peter, E. L., Muluye, R. A., Tolo, C. U., & Ogwang, P. E. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107815 · Cited by 107
Toro-Ramos, T., Michaelides, A., Anton, M., Karim, Z., Kang-Oh, L., Argyrou, C., Loukaidou, E., Charitou, M. M., Sze, W., & Miller, J. D. (2020) · JMIR mHealth and uHealth · doi:10.2196/17842 · Cited by 107
Reflections on inositol(s) for PCOS therapy: steps toward success
Nestler, J. E., & Unfer, V. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1054802 · Cited by 106 · cited 2×
“Mechanism of Action Inositols [69–71] Myo-inositol (MI) and D-chiro-inositol (DCI) act as insulin second messengers.”
BackgroundMicrobiota and Diabetes Mellitus: Role of Lipid Mediators
Salazar, J. J., Angarita, L., Morillo, V., Navarro, C., Martínez, M. S., Chacín, M., Torres, W., Rajotia, A., Rojas, M., Cano, C., et al. (2020) · Nutrients · doi:10.3390/nu12103039 · Cited by 106
Lifestyle modification in the management of the metabolic syndrome: achievements and challenges
Giulio Marchesini, G. (2010) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmsott.s13860 · Cited by 105
Self-citationRao, M., Gao, C., Xu, L., Jiang, L., Zhu, J., Chen, G., Law, B. Y. K., & Xu, Y. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5101423 · Cited by 104
Shan, Z., Bao, W., Zhang, Y., Rong, Y., Wang, X., Jin, Y., Song, Y., Yao, P., Sun, C., Hu, F. B., et al. (2014) · Diabetes · doi:10.2337/db13-0606 · Cited by 99
Dietary Approaches in the Management of Diabetic Patients with Kidney Disease
Ko, G., Kalantar-Zadeh, K., Goldstein-Fuchs, J., & Rhee, C. (2017) · Nutrients · doi:10.3390/nu9080824 · Cited by 97
Verboeket-van de Venne, W. P., Westerterp, K. R., van Hoek, B., & Swart, G. R. (1995) · Gut · doi:10.1136/gut.36.1.110 · Cited by 96
Al-Aubaidy, H. A., Dayan, A., Deseo, M. A., Itsiopoulos, C., Jamil, D. A., Hadi, N. R., & Thomas, C. J. (2021) · Nutrients · doi:10.3390/nu13041133 · Cited by 94
Yin, R. V., & Phung, O. J. (2015) · Nutrition Journal · doi:10.1186/1475-2891-14-14 · Cited by 93
MANDERS, R. J. F., Little, J. P., Forbes, S. C., & Candow, D. G. (2012) · Nutrients · doi:10.3390/nu4111664 · Cited by 91
Hypomagnesaemia and risk for metabolic glucose disorders: a 10‐year follow‐up study
Guerrero‐Romero, F., Rascón‐Pacheco, R. A., Rodríguez‐Morán, M., De La Peña, J. E., & Wacher, N. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01957.x · Cited by 88
Sodium and Its Role in Cardiovascular Disease – The Debate Continues
Kong, Y. W., Baqar, S., Jerums, G., & Ekinci, E. I. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00164 · Cited by 86
Baldassarre, M., Naldi, M., Zaccherini, G., Bartoletti, M., Antognoli, A., Laggetta, M., Gagliardi, M., Tufoni, M., Domenicali, M., Waterstradt, K., et al. (2021) · Hepatology · doi:10.1002/hep.31798 · Cited by 86
Self-citationNiacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials
Goldie, C., Taylor, A. J., Nguyen, P., McCoy, C., Zhao, X.-Q., & Preiss, D. (2016) · Heart · doi:10.1136/heartjnl-2015-308055 · Cited by 85
Vitamin D supplementation for chronic liver diseases in adults
Bjelakovic, G., Nikolova, D., Bjelakovic, M., & Gluud, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011564.pub2 · Cited by 84
Veronese, N., Stubbs, B., Punzi, L., Soysal, P., Incalzi, R. A., Saller, A., & Maggi, S. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.02.005 · Cited by 84
Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness
Costello, R. B., Dwyer, J. T., & Bailey, R. L. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw011 · Cited by 83
Nutritional issues in patients with obesity and cirrhosis
Schiavo, L., Busetto, L., Cesaretti, M., Zelber-Sagi, S., Deutsch, L., & Iannelli, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i30.3330 · Cited by 82
Ruz, M., Carrasco, F., Rojas, P., Basfi-fer, K., Hernández‐Rodas, M. C., & Pérez, Á. (2019) · Biological Trace Element Research · doi:10.1007/s12011-018-1611-8 · Cited by 82
Prevention and treatment of sarcopenic obesity in women
Petroni, M. L., Caletti, M. T., Dalle Grave, R., Bazzocchi, A., Aparisi Gómez, M. P., & Marchesini, G. (2019) · Nutrients · doi:10.3390/nu11061302 · Cited by 82 · cited 2×
“High protein (1.2– 1.4 g/kg) hypocaloric diets—either exclusively food-based or including protein supplements, both as an adjunct to resistance training—have proven effective for preventing muscle mass loss during weight-reduction diets in women with obesity [173].”
BackgroundInfluentialSelf-citationProbiotics for the treatment of type 2 diabetes: A review of randomized controlled trials
Tiderencel, K. A., Hutcheon, D. A., & Ziegler, J. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3213 · Cited by 82
Rajpal, A., & Ismail‐Beigi, F. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14080 · Cited by 81
The treatment of hepatic encephalopathy
Morgan, M. Y., Blei, A. T., Grüngreiff, K., Jalan, R., KIRCHEIS, G., Marchesini, G., Riggio, O., & Weißenborn, K. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-007-9060-7 · Cited by 74
Self-citationResveratrol for adults with type 2 diabetes mellitus
Jeyaraman, M. M., Al-Yousif, N. S. H., Singh Mann, A., Dolinsky, V. W., Rabbani, R., Zarychanski, R., & Abou-Setta, A. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011919.pub2 · Cited by 74
Yang, J., Yin, J., Gao, H., Xu, L., Wang, Y., Xu, L., & Li, M. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/363845 · Cited by 72
Horne, B. D., Grajower, M. M., & Anderson, J. L. (2020) · JAMA · doi:10.1001/jama.2020.3908 · Cited by 71
Gómez-Arbeláez, D., Lahera, V., Oubiña, P., Valero-Muñoz, M., de las Heras, N., Rodríguez, Y., García, R. G., Camacho, P. A., & López-Jaramillo, P. (2013) · Mediators of Inflammation · doi:10.1155/2013/285795 · Cited by 70
Insulin-sensitizing and cholesterol-lowering effects of chromium (d-Phenylalanine)3
Yang, X., Li, S., Dong, F., Ren, J. T., & Sreejayan, N. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.01.039 · Cited by 67
Hamdy, O., & Yusof, B. N. M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.010 · Cited by 67
Zinc supplementation improves glucose disposal in patients with cirrhosis
Marchesini, G., Bugianesi, E., Ronchi, M., Flamia, R., Thomaseth, K., & Pacini, G. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90114-7 · Cited by 67
Self-citationWoldeamlak, B., Yirdaw, K., & Biadgo, B. (2019) · The Korean Journal of Gastroenterology · doi:10.4166/kjg.2019.74.6.314 · Cited by 66
Plant-Dominant Low-Protein Diet for Conservative Management of Chronic Kidney DiseasePreprint
Kalantar‐Zadeh, K., Joshi, S., Schlueter, R., et al. (2020) · Preprints.org · doi:10.20944/preprints202005.0516.v1 · Cited by 66
Sarcopenia and liver transplant: The relevance of too little muscle mass
Kallwitz, E. R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.10982 · Cited by 63
The effects of popular diets on type 2 diabetes management
Chester, B., Babu, J. R., Greene, M. W., & Geetha, T. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3188 · Cited by 63
Use and abuse of dietary supplements in persons with diabetes
Hannon, B. A., Fairfield, W. D., Adams, B., Kyle, T., Crow, M., & Thomas, D. M. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-0117-6 · Cited by 61
A Whole Food Plant-Based Diet Is Effective for Weight Loss: The Evidence
Greger, M. (2020) · American Journal of Lifestyle Medicine · doi:10.1177/1559827620912400 · Cited by 59
Body composition in type 2 diabetes: Change in quality and not just quantity that matters
Solanki, J., Makwana, A., Mehta, H., Gokhale, P. A., & Shah, C. J. (2015) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.172376 · Cited by 58
Brown, J., Crawford, T. J., Alsweiler, J. M., & Crowther, C. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012048.pub2 · Cited by 56
Insulin-dependent metabolism of branched-chain amino acids in obesity
Forlani, G., Vannini, P., Marchesini, G., Zoli, M., Ciavarella, A., & Pisi, E. (1984) · Metabolism · doi:10.1016/0026-0495(84)90127-6 · Cited by 55
Self-citationNutritional Supplementation for the Prevention and/or Treatment of Gestational Diabetes Mellitus
Plows, J. F., Reynolds, C. M., Vickers, M. H., Baker, P. N., & Stanley, J. L. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1199-1 · Cited by 55
9. CHROMIUM SUPPLEMENTATION IN HUMAN HEALTH, METABOLIC SYNDROME, AND DIABETES
Maret, W. (2019) · De Gruyter eBooks · doi:10.1515/9783110527872-009 · Cited by 55
Vogtschmidt, Y. D., Raben, A., Faber, I., de Wilde, C., Lovegrove, J. A., Givens, D. I., Pfeiffer, A. F. H., & Soedamah-Muthu, S. S. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.011 · Cited by 54
Gao, C., Rao, M., Huang, W. G., Qin, W., Yan, P., Long, Y., Guo, M., Xu, Y., & Xu, Y. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1127-z · Cited by 52
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy
Formoso, G., BALDASSARRE, M. P. A., Ginestra, F., Carlucci, M. A., Bucci, I., & Consoli, A. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3154 · Cited by 50
Osuka, Y., Kojima, N., Sasai, H., Wakaba, K., Miyauchi, D., Tanaka, K., & Kim, H. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab176 · Cited by 50
Vitamin D deficiency enhances insulin resistance by promoting inflammation in type 2 diabetes.
Wang, W., Zhang, J., Wang, H., Wang, X., & Liu, S. (2019) · Europe PMC (PubMed Central) · Cited by 48
Colosimo, S., Ravaioli, F., Petroni, M. L., Brodosi, L., Marchignoli, F., Barbanti, F. A., Sasdelli, A. S., Marchesini, G., & Pironi, L. (2021) · Liver International · doi:10.1111/liv.14799 · Cited by 45
Self-citationLi, Q., Wen, F., Wang, Y., Li, S., Lin, S., Qi, C., Chen, Z., Qiu, X., Zhang, Y., Zhang, S., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00952-5 · Cited by 44
Tu, D.-Y., Kao, F.-M., Tsai, S., & Tung, T. (2021) · Healthcare · doi:10.3390/healthcare9060650 · Cited by 44
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Petroni, M. L., Brodosi, L., Marchignoli, F., Musio, A., & Marchesini, G. (2019) · Nutrients · doi:10.3390/nu11123048 · Cited by 43
Self-citationNew Frontiers for the Use of IP6 and Inositol Combination in Treating Diabetes Mellitus: A Review
Omoruyi, F. O., Stennett, D., Foster, S. R., & Dilworth, L. (2020) · Molecules · doi:10.3390/molecules25071720 · Cited by 43
Huang, H., Chen, G., Dong, Y. Q., Zhu, Y., & Chen, H. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700438 · Cited by 40
Optimal Protein Intake in Pre-Dialysis Chronic Kidney Disease Patients with Sarcopenia: An Overview
Isaka, Y. (2021) · Nutrients · doi:10.3390/nu13041205 · Cited by 39
Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside
Cicero, A., Tartagni, E., & Ertek, S. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113119990120 · Cited by 36
Chen, S., Jin, X., Shan, Z., Li, S., Yin, J., Sun, T., Luo, C., Yang, W. Q., Yao, P., Kai-feng, Y., et al. (2017) · Nutrients · doi:10.3390/nu9030294 · Cited by 36
Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients
Brodosi, L., Petta, S., Petroni, M. L., Marchesini, G., & Morelli, M. C. (2021) · Transplantation · doi:10.1097/tp.0000000000003867 · Cited by 36
Self-citationSupplements for Diabetes Mellitus: A Review of the Literature
Yilmaz, Z., Piracha, F., Anderson, L., & Mazzola, N. (2016) · Journal of Pharmacy Practice · doi:10.1177/0897190016663070 · Cited by 34
Low, S. K., Pek, S. L. T., Moh, A. M. C., Khin, C. Y. A., Lim, C. L., Ang, S. F., Wang, J., Ang, K., Tang, W. E., Lim, Z., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108777 · Cited by 31
Nutraceuticals for the treatment of sarcopenia in chronic liver disease
Hey, P., Gow, P. J., Testro, A., Apostolov, R., Chapman, B. R., & Sinclair, M. J. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.11.015 · Cited by 30
Xiang, D., Zhang, Q., & Wang, Y. (2020) · Medicine · doi:10.1097/md.0000000000021235 · Cited by 29
Is there a “burnt-out diabetes” phenomenon in patients on hemodialysis?
Abe, M., Hamano, T., Hoshino, J., Wada, A., Inaba, M., Nakai, S., & Masakane, I. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.012 · Cited by 28
Davinelli, S., Nicolosi, D., Cesare, C. D., Scapagnini, G., & Marco, R. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040987 · Cited by 28
Muscle Strength and Glycaemic Control among Patients with Type 2 Diabetes
Bawadi, H. A., Alkhatib, D. H., Abuhijleh, H., Alalwani, J., Majed, L., & Shi, Z. (2020) · Nutrients · doi:10.3390/nu12030771 · Cited by 27
Emerging Treatment Options for Sarcopenia in Chronic Liver Disease
Kim, Y. (2021) · Life · doi:10.3390/life11030250 · Cited by 26
Polo, V., Saibene, A. M., & Pontiroli, A. E. (1998) · Acta Diabetologica · doi:10.1007/s005920050103 · Cited by 25
Long-term treatment of severe obesity: are lifestyle interventions still an option?
Petroni, M. L., Caletti, M. T., Calugi, S., Grave, R. D., & Marchesini, G. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1386551 · Cited by 25
Self-citationNutrition Intervention for Advanced Stages of Diabetic Kidney Disease
Goldstein‐Fuchs, J., & Kalantar‐Zadeh, K. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.3.181 · Cited by 24
Bragança, A. C. C., & Álvares‐da‐Silva, M. R. (2010) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032010000100005 · Cited by 24
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review
D’Anna, R., Santamaria, A., Alibrandi, A., Corrado, F., Benedetto, A. D., & Facchinetti, F. (2019) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.65.s59 · Cited by 22
Rational Use of Protein Supplements in the Elderly—Relevance of Gastrointestinal Mechanisms
Chapman, I. M., Oberoi, A., Giezenaar, C., & Soenen, S. (2021) · Nutrients · doi:10.3390/nu13041227 · Cited by 22
Pharmacological Effects of Niacin on Acute Hyperlipemia
la Paz, S. M., Bermúdez, B., Naranjo, M. C., López, S., Abia, R., & Muriana, F. J. G. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160411142909 · Cited by 21
Syauqy, A., Hsu, C., Lee, H.-A., Rau, H.-H., & Chao, J. C.-J. (2020) · Nutrients · doi:10.3390/nu13010040 · Cited by 21
Sarcopenia: a fate worth challenging
Endocrinology, T. L. D. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70055-5 · Cited by 21
Lombardo, M., Padua, E., Campoli, F., Panzarino, M., Mîndrescu, V., Annino, G., Iellamo, F., & Bellia, A. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01588-4 · Cited by 19
The use of human albumin in patients with cirrhosis: a European survey
Caraceni, P., Pavesi, M., Baldassarre, M., Bernardi, M., & Arroyo, V. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1460203 · Cited by 18
Self-citationThe Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series
Vukotic, R., Raimondi, F., Brodosi, L., Vitale, G., Petroni, M. L., Marchesini, G., & Andreoné, P. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0041 · Cited by 17
Self-citationInositol Supplementation in the Prevention of Gestational Diabetes Mellitus
Tahir, F., & Majid, Z. (2019) · Cureus · doi:10.7759/cureus.5671 · Cited by 16
Research works printed but not linked: 1
- Zimmet, P. (2000, January 17–21). The Negev desert, migration, islands and diabesity: Genes and environment clashing. Proceedings of the Cohen Memorial Lecture 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem, Israel.
Cited by
Ansari, P., Samia, J., Khan, J. T., Rafi, M. R., Rahman, M. S., Rahman, A. B., Abdel‐Wahab, Y. H. A., & Seidel, V. (2023) · Nutrients · doi:10.3390/nu15143266 · Cited by 102
Association of Serum Magnesium with Insulin Resistance and Type 2 Diabetes among Adults in China
Li, W., Jiao, Y., Wang, L., Wang, S., Hao, L., Wang, Z., Wang, H., Zhang, B., Ding, G., & Jiang, H. (2022) · Nutrients · doi:10.3390/nu14091799 · Cited by 61
Evolving paradigms in nutrition therapy for Diabetes: From carbohydrate counting to precision diets
Alum, E. U., Obasi, D. C., Abba, J. N., Aniokete, U. C., Okoroh, P. N., & Akwari, A. A. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100622 · Cited by 51
Enteric neuropathy in diabetes: Implications for gastrointestinal function
Abdalla, M. M. I. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i22.2852 · Cited by 45
Yoshida, S., Shiraishi, R., Nakayama, Y., & Taira, Y. (2023) · Nutrients · doi:10.3390/nu15132991 · Cited by 57
Metadata
- Authors
- Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- University of Bologna (IT)
- Corresponding author
- Marchesini, Giulio
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-08-10
- Volume
- 13
- Issue
- 8
- Pages
- 2748
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8401663
- OpenAlex
- W3187758220
- Cited by
- 116
- References
- 204
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 31 · 2023: 22 · 2022: 8 · 2021: 1
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, nutrition, dietary intervention, Mediterranean diet, caloric restriction, sarcopenic obesity, weight loss, dietary adherence, lifestyle intervention, dietary supplements, myo-inositol, vitamin D, micronutrients, probiotics, prebiotics, insulin sensitivity, physical activity, obesity
- MeSH terms
- Diabetes Mellitus, Type 2, Diet, Diabetic, Humans, Patient Compliance, Exercise, Dietary Supplements, Caloric Restriction, Diet, Mediterranean, Nutrition Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.